版本:
中国

BRIEF-Trovagene selected as liquid biopsy provider

Oct 4 Trovagene Inc

* Selected as liquid biopsy provider to participate in first large-scale precision medicine trial for patients with pancreatic cancer

* Selected by Pancreatic Cancer Action Network as liquid biopsy provider to participate in precision medicine trial Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐